Overview / Abstract: |
Series Overview Target Audience Educational Objectives: Describe the mechanistic rationale and recent clinical trial evidence for new targeted treatment options in nonadvanced SM Individualize treatment regimens for nonadvanced SM to reflect symptomatology, patient-reported outcomes, and shared clinical decision making |
Expiration |
Jul 14, 2024 |
Credits / Hours |
0.75 |
Accreditation |
ACCME |
Is This Activity Certified for "Live" Credit? |
YES |
Presenters / Authors / Faculty |
Tracy I. George, MD Anthony P. Fernandez, MD, PhD Matthew P. Giannetti, MD |
Sponsors / Supporters / Grant Providers |
This activity is provided by Global Education Group. (ACCME Credit) This activity is jointly provided by Global Education Group and Integritas Communications. (AANP Credit) This activity is supported by an independent educational grant from Blueprint Medicines Corporation. |
Keywords / Search Terms |
Integritas Communications nonadvanced systemic mastocytosis, SM, assessment techniques, patient education, targeted therapies, Free CE CME Live CE CME |